Principal Financial Group Inc Vista Gen Therapeutics, Inc. Transaction History

Principal Financial Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.12 - $0.3 $1,206 - $3,017	-10,058 Reduced 5.28%	180,504 $21,000
Q4 2022 Feb 09, 2023	BUY	$0.09 - $4.8 $14,625 - $780,028	162,506 Added 579.22%	190,562 $19,000
Q3 2022 Nov 09, 2022	BUY	$0.14 - $4.8 $269 - $9,225	1,922 Added 7.35%	28,056 $4,000
Q2 2022 Aug 10, 2022	SELL	$0.88 - $1.73 $74,729 - $146,911	-84,920 Reduced 76.47%	26,134 $23,000
Q1 2022 May 09, 2022	SELL	$1.14 - $2.09 $43,298 - $79,380	-37,981 Reduced 25.48%	111,054 $138,000
Q4 2021 Feb 09, 2022	BUY	$1.67 - $2.76 $186,647 - $308,471	111,765 Added 299.88%	149,035 $291,000
Q3 2021 Nov 09, 2021	BUY	$2.62 - $3.45 $21,143 - $27,841	8,070 Added 27.64%	37,270 $102,000
Q2 2021 Aug 10, 2021	BUY	$1.96 - $3.15 $57,232 - $91,980	29,200 New	29,200 $0

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.